[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 24, Issue 3 (Iranian South Medical Journal 2021) ::
Iran South Med J 2021, 24(3): 180-187 Back to browse issues page
The Effect of Subcutaneous Immunotherapy in Patients with Asthma and Allergic Rhinitis in Bushehr Province of Iran
Afshin Shirkani1 , Zahra Mohammadi1, Razeah Daryapour1, Erfan Javanmardi2, Shokhrolah Farrokhi 3
1- Department of Immunology, Asthma and Allergy, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
2- Clinical Research Development Center, The Persian Gulf Martyrs Hospital, Bushehr University of Medical Sciences, Bu-shehr, Iran
3- Department of Immunology, Asthma and Allergy, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran , sh.farokhi@bpums.ac.ir
Abstract:   (304 Views)
Background: The use of allergen immunotherapy is one of the definitive treatments for allergic diseases due to the cellular and molecular changes developed in the immune system response. The aim of this study was to assess the efficacy of subcutaneous immunotherapy in patients with allergic diseases presenting to the allergy clinic of Persian Gulf Hospital in Bushehr, Iran.
Materials and Methods: Patients with  respiratory allergic diseases were enrolled in this observational study. The patients who had a positive skin prick test underwent immunotherapy for one year and were randomly included in this study. To evaluate the efficacy of immunotherapy, two questionnaires were completed for all the patients before and one year after the start of immunotherapy, including the Total Nasal Symptom Score (TNSS) and Asthma Control Test (ACT).
Results: A total of 878 patients (53.6% male and 46.4% female) entered the study, including 45.8% who had allergic rhinitis, 25.5% with asthma and 28.5% with both diseases. The mean TNSS was examined for 258 patients before and after immunotherapy and was 13.64 and 5.83 (P<0.001), respectively. Moreover, the mean ACT score before and after immunotherapy was examined for 186 patients and was 1.71 and 17.82 (P<0.001), respectively.
Conclusion: The mean TNSS and ACT score before and after the treatment showed a significant improvement in the patients’ symptoms in both genders, and women showed a relatively better response to immunotherapy. To conclude, immunotherapy is effective in patients with asthma and allergic rhinitis.
Keywords: Subcutaneous immunotherapy, asthma, allergic rhinitis, Total Nasal Symptoms Score (TNSS), Asthma Control Test (ACT)
Full-Text [PDF 411 kb]   (50 Downloads)    
Type of Study: Original | Subject: Respiratory System
Received: 2021/05/31 | Accepted: 2021/07/3 | Published: 2021/09/1
References
1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis And Its Impact On Asthma (ARIA) 2008. Allergy 2008; 63(Suppl 86): 8-160.
2. Bousquet J, Schünemann HJ, Togias A, et al. Next-Generation Allergic Rhinitis And Its Impact On Asthma (ARIA) Guidelines For Allergic Rhinitis Based On Grading Of Recommendations Assessment, Development And Evaluation (GRADE) And Real-World Evidence. J Allergy Clin Immunol 2020; 145(1): 70-80.
3. Adkinson Jr NF, Eggleston PA, Eney D, et al. A Controlled Trial Of Immunotherapy For Asthma In Allergic Children. N Engl J Med 1997; 336(5): 324-31.
4. Masoli M, Fabian D, Holt S, et al. The Global Burden Of Asthma: Executive Summary Of The GINA Dissemination Committee Report. Allergy 2004; 59(5): 469-78.
5. Jalali MM, Nemati S, Nezamdoust F, et al. Frequency Of Allergic Rhinitis And Its Comorbidities In Patients Attending Rasht Amiralmomenin Hospital In Rasht. J Mazandaran Univ Med Sci 2019; 28(170): 194-9. (Persian)
6. Nikolić JM. Improvement Of Diagnostic Reagents For Banana Fruit Allergy. Univ Belgrade (Универзитет у Београду) 2017.
7. Ünal D. Effects Of Perennial Allergen Immunotherapy In Allergic Rhinitis In Patients With/Without Asthma: A-Randomized Controlled Real-Life Study. Int Arch Allergy Immunol 2020; 181(2): 141-8.
8. Abramson MJ, Puy RM, Weiner JM. Injection Allergen Immunotherapy For Asthma. Cochrane Database Syst Rev 2010; (8): CD001186.
9. Soyer OU, Akdis M, Akdis CA. Mechanisms Of Subcutaneous Allergen Immunotherapy. Immunol Allergy Clin North Am 2011; 31(2): 175-90.
10. Tamay Z, Akcay A, Ergin A, et al. Dietary Habits And Prevalence Of Allergic Rhinitis In 6 To 7- Year-Old Schoolchildren In Turkey. Allergol Int 2014; 63(4): 553-62.
11. Assadi T, Gheybi MK, Shirkani A, et al. Study Of Prevalence And Risk Factors Of Asthma And Allergic Diseases Among School Children (6-7 And 13-14 Years) Based On ISAAC Protocol In Jam City, Bushehr Province In 2014. Iran South Med J 2017; 19(6): 972-81. (Persian)
12. Blackwell DL, Lucas JW, Clarke TC. Summary Health Statistics For US Adults: National Health Interview Survey, 2012. Vital Health Stat 10 2014; (260): 1-161.
13. Akdis CA, Akdis M. Mechanisms Of AllergenSpecific Immunotherapy. J Allergy Clin Immunol 2011; 127(1): 18-27.
14. Akdis CA. Therapies For Allergic Inflammation: Refining Strategies To Induce Tolerance. Nat Med 2012; 18(5): 736-49.
15. Burks AW, Calderon MA, Casale T, et al. Update On Allergy Immunotherapy: American Academy Of Allergy, Asthma & Immunology/European Academy Of Allergy And Clinical Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2013; 131(5): 1288-96.
16. Ross RN, Nelson HS, Finegold I. Effectiveness Of Specific Immunotherapy In The Treatment Of Asthma: A Meta-Analysis Of Prospective, Randomized, Double-Blind, Placebo-Controlled Studies. Clin Ther 2000; 22(3): 329-41.
17. Basomba A, Tabar AI, De Rojas DHF, et al. Allergen Vaccination With A Liposome-Encapsulated Extract Of Dermatophagoides Pteronyssinus: A Randomized, Double-Blind, Placebo-Controlled Trial In Asthmatic Patients. J Allergy Clin Immunol 2002; 109(6): 943-8.
18. Uriarte SA, Sastre J. Subcutaneous Immunotherapy With High-Dose Cat And Dog Extracts: A Real-Life Study. J Investig Allergol Clin Immunol 2020; 30(3): 169-74.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shirkani A, Mohammadi Z, Daryapour R, Javanmardi E, Farrokhi S. The Effect of Subcutaneous Immunotherapy in Patients with Asthma and Allergic Rhinitis in Bushehr Province of Iran. Iran South Med J. 2021; 24 (3) :180-187
URL: http://ismj.bpums.ac.ir/article-1-1474-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 3 (Iranian South Medical Journal 2021) Back to browse issues page
دانشگاه علوم پزشکی بوشهر، طب جنوب ISMJ

Iranian South Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License which allows users to read,
copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Copyright © 2017, Iranian South Medical Journal| All Rights Reserved

Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4341